Tomas Guilarte to Disease Models, Animal
This is a "connection" page, showing publications Tomas Guilarte has written about Disease Models, Animal.
Connection Strength
0.410
-
Rodichkin AN, Brown AM, Devabathini P, McGlothan JL, Chen S, Pattammattel A, Chu YS, Lin T, Pontow DD, Abilmouna K, Kapoor R, Hardin SE, Pushkar Y, Sillitoe RV, Guilarte TR. Cerebellar dysfunction in a mouse model of childhood-onset manganese-induced dystonia parkinsonism. Neurobiol Dis. 2025 11; 216:107115.
Score: 0.155
-
Martinez-Perez DA, McGlothan JL, Rodichkin AN, Abilmouna K, Bursac Z, Lopera F, Villegas-Lanau CA, Guilarte TR. Amyloid-? plaque-associated microglia drive TSPO upregulation in Alzheimer's disease. Acta Neuropathol. 2025 Jul 17; 150(1):6.
Score: 0.153
-
Abazyan B, Dziedzic J, Hua K, Abazyan S, Yang C, Mori S, Pletnikov MV, Guilarte TR. Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study. Schizophr Bull. 2014 May; 40(3):575-84.
Score: 0.066
-
Roberts RA, Aschner M, Calligaro D, Guilarte TR, Hanig JP, Herr DW, Hudzik TJ, Jeromin A, Kallman MJ, Liachenko S, Lynch JJ, Miller DB, Moser VC, O'Callaghan JP, Slikker W, Paule MG. Translational Biomarkers of Neurotoxicity: A Health and Environmental Sciences Institute Perspective on the Way Forward. Toxicol Sci. 2015 Dec; 148(2):332-40.
Score: 0.020
-
Agusti A, Dziedzic JL, Hernandez-Rabaza V, Guilarte TR, Felipo V. Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18?kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition. Metab Brain Dis. 2014 Dec; 29(4):955-63.
Score: 0.017